Literature DB >> 6498742

Breast self-examination among diagnosed breast cancer patients.

S E Taylor, R R Lichtman, J V Wood, A Z Bluming, G M Dosik, R L Leibowitz.   

Abstract

The practice of breast self-examination (BSE) was explored by personal interview in a sample of women with diagnosed breast cancer. Despite physician recommendations to practice BSE, only 43% of those interviewed were examining themselves regularly, a figure that is little different from that of the general population. Predictors of BSE were age (older women were less likely to practice) and practice of BSE before diagnosis. Factors contributing to nonpractice were judged to be: (1) the patients' beliefs that occasional examinations by physicians are a sufficient substitute for BSE; (2) the patients' perceptions that BSE is discretionary and not truly "medical"; and (3) the fact that BSE may raise patients' anxiety over cancer without affecting its likelihood. It was concluded that the practice of BSE among diagnosed patients could be increased if physicians stress its importance and provide systematic instruction or reinstruction in its practice.

Entities:  

Mesh:

Year:  1984        PMID: 6498742     DOI: 10.1002/1097-0142(19841201)54:11<2528::aid-cncr2820541136>3.0.co;2-u

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  3 in total

1.  Practice of breast self examination: disease extent at diagnosis and patterns of surgical care. A report from an Italian study. GIVIO (Interdisciplinary Group for Cancer Care Evaluation).

Authors: 
Journal:  J Epidemiol Community Health       Date:  1991-06       Impact factor: 3.710

2.  Breast self-examination practices and attitudes of women with and without a history of breast cancer.

Authors:  L M Strauss; L J Solomon; M C Costanza; J K Worden; R S Foster
Journal:  J Behav Med       Date:  1987-08

3.  Current evaluation of the contribution of self-examination to secondary prevention of breast cancer.

Authors:  V F Semiglazov; V M Moiseyenko
Journal:  Eur J Epidemiol       Date:  1987-03       Impact factor: 8.082

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.